CA3011746C - Technologie fit-immunoglobuline et ses utilisations - Google Patents

Technologie fit-immunoglobuline et ses utilisations

Info

Publication number
CA3011746C
CA3011746C CA3011746A CA3011746A CA3011746C CA 3011746 C CA3011746 C CA 3011746C CA 3011746 A CA3011746 A CA 3011746A CA 3011746 A CA3011746 A CA 3011746A CA 3011746 C CA3011746 C CA 3011746C
Authority
CA
Canada
Prior art keywords
seq
polypeptide
binding protein
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3011746A
Other languages
English (en)
Other versions
CA3011746A1 (fr
Inventor
Chengbin Wu
Original Assignee
Epimab Biotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epimab Biotherapeutics Inc filed Critical Epimab Biotherapeutics Inc
Priority claimed from PCT/US2017/016691 external-priority patent/WO2017136820A2/fr
Publication of CA3011746A1 publication Critical patent/CA3011746A1/fr
Application granted granted Critical
Publication of CA3011746C publication Critical patent/CA3011746C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne des protéines de liaison multivalentes et multispécifiques qui sont capables de liaison à deux antigènes ou plus, ou à deux épitopes ou plus. Des procédés de production et d'utilisation desdites protéines de liaison multivalentes et multispécifiques, comprenant des procédés d'utilisation de celles-ci dans la prévention ou le traitement de diverses maladies, ou la détection d'antigènes spécifiques in vitro ou in vivo sont en outre décrits.
CA3011746A 2016-02-06 2017-02-06 Technologie fit-immunoglobuline et ses utilisations Active CA3011746C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2016/073722 2016-02-06
CN2016073722 2016-02-06
PCT/US2017/016691 WO2017136820A2 (fr) 2016-02-06 2017-02-06 Technologie fit-immunoglobuline et ses utilisations

Publications (2)

Publication Number Publication Date
CA3011746A1 CA3011746A1 (fr) 2017-08-10
CA3011746C true CA3011746C (fr) 2025-09-23

Family

ID=

Similar Documents

Publication Publication Date Title
US12540185B2 (en) Fabs-in-tandem immunoglobulin and uses thereof
US10266608B2 (en) Fabs-in-tandem immunoglobulin and uses thereof
CA3011746C (fr) Technologie fit-immunoglobuline et ses utilisations
BR112018015485B1 (pt) Proteína de ligação biespecífica, respectivo uso, proteína que possui uma ou mais substituições conservativas de aminoácidos e composição farmacêutica
HK1227906B (en) Fabs-in-tandem immunoglobulin and uses thereof
HK1234423B (zh) 串联fab免疫球蛋白及其用途
HK1234423A1 (en) Fabs-in-tandem immunoglobulin and uses thereof